de cotation: IIN
The Group's principal
activity is to develop and commercialise polymer implants for the
fixation market. The Group's expertise and technology lies in the
and manufacture of biodegradable polymer devices, such as plates,
pins and membranes. These implants are used to enhance the healing of
injuries, such as those caused by trauma or by reconstructive surgery.
The Group has four operating segments: Craniomaxillofacial Surgery,
Trauma, Sports Medicine and Dental Surgery. Product brands include
Trinion, OTPS Pin, OTPS Ankle Fixation, OTPS Mesh, OTPS Min-Planting,
Planting System, Optima and Optimaplus. The Group operates in Europe,
Asia, Australia and Pacific area.